Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation
Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 1901-1923
DOI: 10.1021/acs.jmedchem.4c02643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 02.01.2025. Verfasst von Lubov V Krylova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lobachevsky State University of Nizhny Novgorod, Gagarina av. 23, Nizhny Novgorod 603950, Russian Federation. Hauptthemen laut MEDLINE: Drug Design, Mice, Nude, Photochemotherapy, Photosensitizing Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
In this report, we developed novel chlorin/arylaminoquinazoline conjugates for targeted photodynamic therapy of cancer. The synthesized photosensitizers consisted of chlorin-e6 metallocomplexes (Zn, In, or Pd) conjugated with arylaminoquinazoline ligands with high affinity for epidermal growth factor receptors (EGFR). Additionally, the selectivity and antitumor properties of the conjugates were investigated in the EGFR-expressing A431 human tumor cell line in vitro. Among the tested molecules, the In-containing conjugate effectively inhibited tumor cell proliferation at nanomolar concentrations, a rare property for conventional photosensitizers. In in vivo experiments, the conjugates rapidly accumulated at the tumor site in nude mice bearing A431 xenograft tumors. Subsequent distribution analysis among different tissues was carried out using fluorescence imaging and elemental analysis. Finally, we demonstrated that the most promising In-containing conjugate was capable of inhibiting xenograft tumor growth in mice through combinational therapy. This therapeutic approach, combined with the conjugate's confirmed safety profile, highlights its potential for effective and safe cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lobachevsky State University of Nizhny Novgorod, Gagarina av. 23, Nizhny Novgorod 603950, Russian Federation.
- Uppsala University, Dag Hammarskjölds väg, 20751 85 Uppsala, Sweden.
- G.A. Krestov Institute of Solution Chemistry, Russian Academy of Sciences, Ivanovo 153045, Russian Federation.
- Institute of Macroheterocyclic Compounds, Ivanovo State University of Chemistry and Technology, Ivanovo 153012, Russian Federation.
- N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prosp., Moscow 119991, Russian Federation.
ORCID-Profile: Vasilii F Otvagin, Galina P Gribova, Ivan V Zelepukin, Alexander V Nyuchev, Philipp K Morshnev, Sergey Z Vatsadze, Irina V Balalaeva, Alexey Yu Fedorov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Krylova, L. V., Otvagin, V. F., Gribova, G. P., Kuzmina, N. S., Fedotova, E. A., Zelepukin, I. V., Nyuchev, A. V., Kustov, A. V., Morshnev, P. K., Berezin, D. B., Koifman, M. O., Vatsadze, S. Z., Balalaeva, I. V., & Fedorov, A. Y. (2025). Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation. Journal of Medicinal Chemistry, 68(2), 1901-1923. https://doi.org/10.1021/acs.jmedchem.4c02643
Vancouver
Krylova LV, Otvagin VF, Gribova GP, Kuzmina NS, Fedotova EA, Zelepukin IV, et al. Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation. Journal of Medicinal Chemistry. 2025;68(2):1901-1923. doi:10.1021/acs.jmedchem.4c02643
BibTeX
@article{Krylova2025,
author = {Krylova, Lubov V and Otvagin, Vasilii F and Gribova, Galina P and Kuzmina, Natalia S and Fedotova, Ekaterina A and Zelepukin, Ivan V and Nyuchev, Alexander V and Kustov, Andrey V and Morshnev, Philipp K and Berezin, Dmitry B and Koifman, Mikhail O and Vatsadze, Sergey Z and Balalaeva, Irina V and Fedorov, Alexey Yu},
title = {Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {2},
pages = {1901--1923},
doi = {10.1021/acs.jmedchem.4c02643}
}
EUVIMED